WPC-1101

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instanceOf chemical compound
gptkbp:affiliatedWith gptkb:University_of_Science
gptkbp:built scalability issues
gptkbp:chemicalFormula C12H16N2O2
amide
contains a phenyl ring
gptkbp:clinicalTrials ongoing
antibiotic therapy
promising results
gptkbp:collaborations international partnerships
gptkbp:compatibleWith antimicrobial
gptkbp:competitors gptkb:WPC-1103
gptkbp:composedOf high yield
via acylation reaction
gptkbp:condition requires acidic catalyst
gptkbp:dissolved soluble in ethanol
gptkbp:drugInterdiction oral bioavailability
gptkbp:environmental_impact minimal impact
gptkbp:environmentalImpact low toxicity
gptkbp:financial_aid stable under normal conditions
gptkbp:funding government grants
gptkbp:future_plans further clinical trials
https://www.w3.org/2000/01/rdf-schema#label WPC-1101
gptkbp:iceClass 300 °C
150 °C
gptkbp:impact none reported
gptkbp:isATypeOf 123456-78-9
gptkbp:judgingCriteria HPLC
gptkbp:market available through chemical suppliers
gptkbp:marketedAs in development
gptkbp:nutritionalValue liver metabolism
gptkbp:origin N-(4-(dimethylamino)phenyl)-2-hydroxy-2-(4-methylphenyl)acetamide
gptkbp:patentAssignee gptkb:XYZ_Pharmaceuticals
gptkbp:patentFilingDate 2011-05-15
gptkbp:patentStatus patented
gptkbp:publications published in peer-reviewed journals
gptkbp:regulatoryCompliance pending
approved for research use
gptkbp:related_to WPC-1102
gptkbp:releaseYear 2010
gptkbp:research effective against resistant strains
gptkbp:researchInterest drug development
gptkbp:safety wear gloves
gptkbp:safety_features completed
gptkbp:safetyFeatures handle with care
gptkbp:storage store in a cool, dry place
gptkbp:targets bacteria
gptkbp:texture NMR
gptkbp:triggerType inhibits bacterial cell wall synthesis
gptkbp:uses pharmaceutical research
gptkbp:waterManagement urinary excretion
gptkbp:weight 220.27 g/mol